Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
Original Studies

A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study

Kapoor, Ekta MBBS, FACP1,2,3; Faubion, Stephanie MD1,2; Hurt, Ryan T. MD, PhD1; Fischer, Karen MS4; Schroeder, Darrell MS4; Fokken, Shawn CCRP1; Croghan, Ivana T. PhD1,5,6,7

Author Information
doi: 10.1097/GME.0000000000001599

Abstract

Erratum

In an article appearing in volume 27, pages 1228-1235, titled “A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study,” there is an error with missing NIH funding. Under the Funding/support section on page 1229, the text should read, “Dr. Kapoor is funded in part by the NIH (NIH SCORE Grant U54 AG044170 - Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease).” The correction has been made online. The authors apologize for this error.

Menopause. 28(2):229, February 2021.

© 2020 by The North American Menopause Society